SH
Sanjay Harakchand Gugle
About Sanjay Harakchand Gugle
Data last updated:
Sanjay Harakchand Gugle is a Director at H.U.Gugle Biotech Private Limited (since 2016) and Director at Trans Pharmaceuticals Private Limited (since 2010). The companies operate in Agriculture and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.89 Cr; the largest is H.U.Gugle Biotech Private Limited at ₹5.81 Cr (FY 2025). Earlier, Sanjay Harakchand Gugle was a Director at Huge Suntech Private Limited (2016–2025) and Director at Zenesis Remedies Private Limited (from 2002).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 H.U.Gugle Biotech Private Limited U73100KA2003PTC032149 | Director | 30 Nov 2016 | 2003 | ₹5.81 Cr (FY 2025) | Active |
 Trans Pharmaceuticals Private Limited U24112PN2010PTC136897 | Director | 20 Jul 2010 | 2010 | ₹8.5 Lakh (FY 2021) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Huge Suntech Private Limited U35105PN2016PTC158210 | Director | 03 Feb 2016 | 2016 | Active | |
| Zenesis Remedies Private Limited U24231PN2002PTC017037 | Director | 05 Jun 2002 | 2002 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Harakchand Gugle
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shailesh Kantilal Kathariya | 00722390 | H.U.Gugle Biotech Private Limited | Director |
| Ganesh Vishwasrao Chintawar | 07017866 | Trans Pharmaceuticals Private Limited | Director |
| Satish Shankarrao Gadewar | 07017813 | Trans Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Harakchand Gugle
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Harakchand Gugle
Sanjay Harakchand Gugle currently holds 2 directorships: H.U.Gugle Biotech Private Limited (Director, since 30 Nov 2016, revenue ₹5.81 Cr (FY 2025)); Trans Pharmaceuticals Private Limited (Director, since 20 Jul 2010, revenue ₹8.5 Lakh (FY 2021)).
Sanjay Harakchand Gugle was first appointed on 05 Jun 2002 as Director at Zenesis Remedies Private Limited. The most recent appointment on record is 30 Nov 2016 at H.U.Gugle Biotech Private Limited.
The 2 current companies of Sanjay Harakchand Gugle that report revenue have a combined latest revenue of ₹5.89 Cr: H.U.Gugle Biotech Private Limited ₹5.81 Cr (FY 2025); Trans Pharmaceuticals Private Limited ₹8.5 Lakh (FY 2021).
Sanjay Harakchand Gugle held 2 earlier board appointments: Huge Suntech Private Limited (Director, 03 Feb 2016 to 07 Jan 2025); Zenesis Remedies Private Limited (Director, from 05 Jun 2002).
The current boards of Sanjay Harakchand Gugle's companies include Shailesh Kantilal Kathariya (H.U.Gugle Biotech Private Limited), Ganesh Vishwasrao Chintawar (Trans Pharmaceuticals Private Limited), Satish Shankarrao Gadewar (Trans Pharmaceuticals Private Limited).